期刊文献+

正常人外周血单个核细胞TRAIL受体的表达及意义 被引量:2

Expression of TRAIL receptors on the PBMC of healthy people
在线阅读 下载PDF
导出
摘要 目的:检测肿瘤坏死因子相关凋亡诱导配体(TRAIL)的受体在正常人外周血单个核细胞上的表达,并探讨其意义。方法:采用半定量逆转录聚合酶链反应(RT-PCR)和流式细胞术,对TRAIL受体的表达分别进行RNA水平和蛋白水平的检测。结果:各受体经RT-PCR和流式细胞术检出的阳性率分别为DR4(50%、60%)、DR5(100%、100%)、DcR1(100%、100%)、DcR2(60%、70%),其中死亡受体DR5和诱骗受体DcR1的表达阳性率最高,均为100%。RT-PCR和流式细胞术均显示:能够诱导凋亡反应的死亡受体中,DR5表达显著高于死亡受体DR4P<0.05;能够竞争性阻断TRAIL诱导的凋亡反应的诱骗受体中,DcR1表达显著高于诱骗受体DcR2P<0.05。结论:DR5和DcR1是外周血单个核细胞PBMC上TRAIL受体系统的主要成员,在TRAIL诱导的细胞凋亡中起关键作用。 Objective: To detect the expression of TRAIL receptors on PBMC of healthy people and explore their significance. Methods: The expressions of TRAIL receptors were assayed by semiquantitive RT-PCR and flowcytometry. Results: Among all of the four receptors, the expression of DR5 is much higher than that of DR4(P<0.05); DcR1 is far higher than DcR2 (P<0.05). DR5 and DcR1 have the highest positive rate 100%. Conclusions: DR5 and DcR1 may play a key role in the apoptotic reaction of PBMC induced by TRAIL.
出处 《山东大学学报(医学版)》 CAS 2004年第1期23-25,共3页 Journal of Shandong University:Health Sciences
基金 国家自然科学基金资助项目30070341 30128023
关键词 淋巴细胞 受体 TRAIL 逆转录聚合酶链反应 流式细胞术 表达 Lymphocyte Receptor, TRAIL Reverse transcriptase polymerase chain reaction Flowcytometry Expression
  • 相关文献

参考文献7

  • 1季军捷,卫立辛,李晓东,吴孟超,郭亚军.激活淋巴细胞中TRAIL及其受体表达的初步研究[J].第二军医大学学报,2002,23(7):788-790. 被引量:2
  • 2Nagata S. Apoptosis by death factor[J]. Cell, 1997,88:355.
  • 3Wiley SR, Schooley K, Smolak PJ,et al. Identification and characterization of new member of the TNF family that induces apoptosis[J]. Immunity, 1995, 3(6):673.
  • 4Anna S, Enrico G, Fulvio DR, et al. Involvement of the cyclin-dependent kinase-4 inhibitor(CDKN2) gene in the pathogenensis of lymphoid blast crisis of chronic myelogenous leukaemia [J].Bri J Haematol,1995, 91:625.
  • 5Griffith TS, Chin WA, Jackson GC, et al. Intracellular regulation of Trail-induced apoptosis in human melanoma cells[J]. J Immunol, 1998, 161(6):2833.
  • 6Yndestad A, Kristian Damas J, Geir Eiken H, et al.Increased gene expression of tumornecrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure[J]. Cardiovasc Res,2002, 54(1):175.
  • 7Miura Y, Misawa N, Kawano Y, et al. Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection [J]. Proc Natl Acad Sci USA, 2003, 100(5):2777.

二级参考文献8

  • 1[1]Scaffidi C, Kirchhoff S, Peter HE, et al. Apoptosis signaling in lymphocytes[J]. Curr Opin Immuno, 1999,11(3):277-285.
  • 2[2]Wiley SR, Schooley K, Smolak PG, et al. Identification and characterization of a new member of the TNF family that induces apoptosis[J]. Immunity,1995,3(6):673-682.
  • 3[3]Simonet WS,Laccy DL,Dunstan CR,et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density[J]. Cell,1997,89(2):309-319.
  • 4[4]Emery JG, McDonnell P, Brigham BM, et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL[J]. J Biol Chem,1998, 273(23):14363-14367.
  • 5[5]Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors[J]. Curr Opin Cell Biol, 1999,11(2):255-260.
  • 6[6]Ozawa F, Friess H, Kleeff J, et al. Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer[J]. Cancer Lett, 2001,163(1):71-81.
  • 7[7]Nimmanapalli R, Perkins CL, Orlando M, et al. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels[J]. Cancer Res,2001,61(2):759-763.
  • 8[8]Jeremias I, Herr I, Boehler T, et al. TRAIL/Apo-2 ligand-induced apoptosis in human T cells[J]. Eur J Immunol, 1998,28(1):143-152.

共引文献1

同被引文献47

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部